|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,766 GBX | +2.11% |
|
-0.45% | +21.81% |
| May. 31 | US FDA approves Moderna's RSV vaccine, its second marketed product | RE |
| May. 30 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
May 16 (Reuters) - GSK plc:
* GSK ANNOUNCES INTENTION TO SELL SHARES IN HALEON
* GSK ANNOUNCES INTENTION TO SELL APPROXIMATELY 385M SHARES IN HALEON Source text for Eikon: Further company coverage:
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,766 GBX | +2.11% | -0.45% | 89.9B | ||
| 325.1 GBX | +0.12% | +0.65% | 37.79B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +21.81% | 89.9B | |
| +40.73% | 734B | |
| +32.83% | 591B | |
| -6.30% | 350B | |
| +15.15% | 315B | |
| +4.05% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +6.17% | 161B |
GSK PLC 
